|
Prescription Drug Search
Strengths available for Omacor:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about MyGlobalPharmacy.com
List of countries where we can ship Omacor:
- Austria
- Bahamas
- Bahrain
- Barbados
- Belarus
- Belgium
- Bolivia
- Brazil
- China
- Colombia
- Cyprus
- Czech Republic
- Denmark
- Dominican Republic
- Egypt
- Finland
- Georgia
- Guam
- India
- Iran
- Jordan
- Lebanon
- Luxembourg
- Malta
- Mauritius
- Monaco
- Morocco
- Peru
- Poland
- Portugal
- Russian Federation
- Singapore
- South Africa
- Sri Lanka
- Switzerland
- Tunisia
- Ukraine
- United Arab Emirates
- United Kingdom, UK
- United States, US
Latest news releases on Omacor:
Omega-3-acid ethyl esters - Comprehensive patent search - PR Newswire
Omega-3-acid ethyl esters innovator: olvay (Omacor); Reliant (Lovaza, Omacor); Pronova (Omacor); Ferrer (Omacor) Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading ...
A New Drug in the Horizon to Increase HDL Good Cholesterol levels - PR-USA.net
Some of the cholesterol lowering drugs in BMD product range is Lipitor (atorvastatin), Mevacor (lovastatin), Advicor (niacin / lovastatin), Omacor (omega 3 acid ethyl esters), Zocor (simvastatin) and Vytorin (ezetimibe/simvastatin). They also carry ...
Pronova BioPharma ASA: Strong Progress Towards Diversification - ad-hoc-news.de
The composition patent covering Omacor® in most European territories expired in August 2009, and this is the first known marketing authorisation of a generic pharmaceutical product based on Pronova BioPharma's active pharmaceutical ingredient (API).
Pronova BioPharma AS : Pronova BioPharma ASA: Strong Progress Towards Diversification - 4-traders (press release)
The composition patent covering Omacor® in most European territories expired in August 2009, and this is the first known marketing authorisation of a generic pharmaceutical product based on Pronova BioPharma's active pharmaceutical ingredient (API).
